PDMR/Director Dealing

RNS Number : 1870O

Omega Diagnostics Group PLC

08 June 2022

 

OMEGA DIAGNOSTICS GROUP PLC

("Omega" or the "Company" or the "Group")

PDMR/Director Dealing

Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Health & Nutrition and Global Health products, announces that, following the general meeting held on 6 June 2022 and Admission on 8 June 2022, the following Directors participated in the Fundraising and their resultant holdings are detailed in the table below.

Director	Board Position	Number of Subscription Shares at the Issue Price	Amount (£)	Resultant holding	Resultant percentage holding of Enlarged Issued Share Capital
Simon Douglas1	Chairman	500,000	2 0,000	500,000	0.21%
Jag Grewal2	CEO	500,000	20,000	735,746	0.31%
Chris Lea3	CFO	500,000	20,000	500,000	0.21%
Jeremy Millard4	Non-Executive Director	500,000	20,000	1,025,000	0.43%

Capitalised terms not otherwise defined in the text of this announcement have the meanings given to them in the Company's circular dated 13 May 2022.

Contacts: 

Omega Diagnostics Group PLC		www.omegadx.com
Jag Grewal, Chief Executive Officer		via Walbrook PR
Chris Lea, Chief Financial Officer
finnCap Ltd		Tel: [phone]
Geoff Nash/Edward Whiley/George Dollemore (Corporate Finance)
Alice Lane/ Harriet Ward (ECM)
Walbrook PR Limited	Tel: [phone] or [e-mail]
Paul McManus	Mob: [phone]
Lianne Applegarth	Mob: [phone]
Sam Allen	Mob: [phone]

About Omega Diagnostics Group PLC

Omega manufactures and distributes high quality in-vitro diagnostic products for use in hospitals, clinics, laboratories and healthcare practitioners in over 70 countries and specialise in the areas of health and nutrition and global health.

www.omegadx.com

Notification of transactions of persons discharging managerial responsibilities and persons closely associated with them

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	1)  Simon Douglas 2)  Jag Grewal 3)  Chris Lea 4)  Jeremy Millard
2	Reason for the notification
a)	Position/status	1)  Chairman 2)  Chief Executive Officer 3)  Chief Financial Officer 4)  Non-Executive Director
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Omega Diagnostics Group Plc
b)	LEI	2138007U9P4BTZTYIR92
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument  Identification code	Ordinary Shares of 4 pence each   ISIN: GB00B1VCP282
b)	Nature of the transaction	Purchase of Shares
c)	Price(s) and volume(s)	Price(s) Volume(s) 1) £0.04 500,000 2) £0.04 500,000 3) £0.04 500,000 4) £0.04 500,000
d)	Aggregated information  -Aggregated volume  - Price	N/A - single transaction for each Director or PCA
e)	Date of the transaction	6 May 2022
f)	Place of the transaction	London Stock Exchange (AIM)

 

END

 

 

DSHBKFBQBBKDAAK